Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-08-11

Clinical Trial Update: Focal Brachytherapy in Patients With Selected "Low-risk" Prostate Cancer - a Phase-II-trial [Phase 2]

View source ↗

Summary

Phase II clinical trial evaluating focal brachytherapy for selected low-risk prostate cancer patients, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Erlangen-Nürnberg Medical School | Conditions: Prostate Cancer | Phase 2 | Status: RECRUITING